2-BBB Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Restart - Angel

  • Investors
  • 1

2-BBB General Information

Description

Developer of medicines designed to treat brain diseases. The company's medicines combine known disease targets and compounds with established drug delivery systems united with safe targeting technology, enabling patients with brain cancer and neuro-inflammatory diseases to get improved treatment.

Contact Information

Website
www.2-bbb.com
Formerly Known As
to-BBB technologies, BBB Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Leiden Bio Science Park
  • BioPartner Building 2, J.H. Oortweg 19
  • 2333 CH Leiden
  • Netherlands
+31 071
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Vertical(s)
Corporate Office
  • Leiden Bio Science Park
  • BioPartner Building 2, J.H. Oortweg 19
  • 2333 CH Leiden
  • Netherlands
+31 071

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

2-BBB Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Restart - Angel 01-Mar-2015 Completed Restart
8. Bankruptcy: Admin/Reorg 26-Jan-2015 Completed Bankruptcy: Admin/Reorg
7. Later Stage VC (Series C) 30-Jun-2014 Completed Clinical Trials - Phase 4
6. Later Stage VC 25-Apr-2013 Completed Clinical Trials - Phase 4
5. Grant 17-Apr-2012 Completed Clinical Trials - Phase 4
4. Grant 29-Sep-2011 Completed Clinical Trials - Phase 4
3. Later Stage VC 03-Feb-2011 Completed Clinical Trials - Phase 4
2. Early Stage VC (Series A) 06-Jul-2007 $5.38M $5.38M Completed Startup
1. University Spin-Out 01-Jan-2003 Completed Startup
To view 2-BBB’s complete valuation and funding history, request access »

2-BBB Patents

2-BBB Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2680820-A1 Advanced active liposomal loading of poorly water-soluble substances Active 01-Mar-2011
EP-2680820-B1 Advanced active liposomal loading of poorly water-soluble substances Active 01-Mar-2011
ES-2728225-T3 Glutathione based drug delivery system Active 20-Feb-2009
AU-2010216512-A1 Glutathione-based drug delivery system Active 20-Feb-2009
AU-2010216512-B2 Glutathione-based drug delivery system Inactive 20-Feb-2009 A61K31/704
To view 2-BBB’s complete patent history, request access »

2-BBB Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

2-BBB Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Leiden University University
To view 2-BBB’s complete investors history, request access »

2-BBB Investments (1)

2-BBB’s most recent deal was a Joint Venture with EnhanX Biopharm. The deal was made on 01-Aug-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
EnhanX Biopharm 01-Aug-2017 Joint Venture Drug Discovery
To view 2-BBB’s complete investments history, request access »

2-BBB FAQs

  • When was 2-BBB founded?

    2-BBB was founded in 2003.

  • Where is 2-BBB headquartered?

    2-BBB is headquartered in Leiden, Netherlands.

  • What is the size of 2-BBB?

    2-BBB has 14 total employees.

  • What industry is 2-BBB in?

    2-BBB’s primary industry is Drug Discovery.

  • Is 2-BBB a private or public company?

    2-BBB is a Private company.

  • What is 2-BBB’s current revenue?

    The current revenue for 2-BBB is .

  • How much funding has 2-BBB raised over time?

    2-BBB has raised $27.6M.

  • Who are 2-BBB’s investors?

    Leiden University has invested in 2-BBB.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process